This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Graybug Vision, Inc., Mireca Medicines Gmbh. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Innovations of Francois Paquet-Durand
Introduction
Francois Paquet-Durand is a notable inventor based in Tübingen, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of novel compounds that impact cellular signaling pathways.
Latest Patents
Paquet-Durand holds a patent for "Equatorially modified polymer linked multimers of guanosine-3', 5'-cyclic monophosphates." This invention focuses on new equatorially modified polymer linked multimers of guanosine-3', 5'-cyclic monophosphate (cGMP) analogues that inhibit the cGMP-signaling system. The patent also covers related monomeric compounds that may serve as precursors for the multimers and exhibit inhibitory activity. These compounds have potential applications in signal transduction research, modulation of cyclic nucleotide-regulated binding proteins, and various diagnostic applications.
Career Highlights
Francois Paquet-Durand is currently associated with Graybug Vision, Inc., where he continues to innovate in the field of biochemistry. His work has garnered attention for its potential applications in medical research and therapeutic development.
Collaborations
He has collaborated with notable colleagues such as Hans-Gottfried Genieser and Frank Schwede, contributing to advancements in their shared field of expertise.
Conclusion
Francois Paquet-Durand's innovative work in the development of cGMP analogues showcases his commitment to advancing biochemistry and its applications. His contributions are poised to have a lasting impact on research and therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
